nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—CYP2B6—malignant glioma	0.697	1	CbGaD
Simvastatin—Sensory disturbance—Temozolomide—malignant glioma	0.00552	0.0527	CcSEcCtD
Simvastatin—ITGB2—endothelium—malignant glioma	0.00453	0.242	CbGeAlD
Simvastatin—VIIth nerve paralysis—Carmustine—malignant glioma	0.00432	0.0412	CcSEcCtD
Simvastatin—Transaminases increased—Carmustine—malignant glioma	0.00291	0.0278	CcSEcCtD
Simvastatin—Interstitial lung disease—Carmustine—malignant glioma	0.0025	0.0239	CcSEcCtD
Simvastatin—Myopathy—Temozolomide—malignant glioma	0.00244	0.0233	CcSEcCtD
Simvastatin—Interstitial lung disease—Temozolomide—malignant glioma	0.00242	0.0231	CcSEcCtD
Simvastatin—Memory impairment—Temozolomide—malignant glioma	0.00218	0.0208	CcSEcCtD
Simvastatin—Endocrine disorder—Temozolomide—malignant glioma	0.00206	0.0197	CcSEcCtD
Simvastatin—Drug interaction—Carmustine—malignant glioma	0.00191	0.0182	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00171	0.0163	CcSEcCtD
Simvastatin—Gynaecomastia—Carmustine—malignant glioma	0.00158	0.0151	CcSEcCtD
Simvastatin—Diabetes mellitus—Carmustine—malignant glioma	0.00148	0.0141	CcSEcCtD
Simvastatin—Swelling—Carmustine—malignant glioma	0.00146	0.0139	CcSEcCtD
Simvastatin—ITGB2—midbrain—malignant glioma	0.00145	0.0777	CbGeAlD
Simvastatin—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00143	0.0136	CcSEcCtD
Simvastatin—Vascular purpura—Temozolomide—malignant glioma	0.00139	0.0132	CcSEcCtD
Simvastatin—Hepatic failure—Temozolomide—malignant glioma	0.00138	0.0132	CcSEcCtD
Simvastatin—Amnesia—Carmustine—malignant glioma	0.00137	0.0131	CcSEcCtD
Simvastatin—Amnesia—Temozolomide—malignant glioma	0.00132	0.0126	CcSEcCtD
Simvastatin—Purpura—Temozolomide—malignant glioma	0.00129	0.0123	CcSEcCtD
Simvastatin—ITGB2—central nervous system—malignant glioma	0.00115	0.0615	CbGeAlD
Simvastatin—Muscular weakness—Carmustine—malignant glioma	0.00113	0.0108	CcSEcCtD
Simvastatin—ITGB2—cerebellum—malignant glioma	0.00112	0.0601	CbGeAlD
Simvastatin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00112	0.0107	CcSEcCtD
Simvastatin—Muscular weakness—Temozolomide—malignant glioma	0.0011	0.0105	CcSEcCtD
Simvastatin—Bronchitis—Temozolomide—malignant glioma	0.00103	0.00985	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000998	0.00952	CcSEcCtD
Simvastatin—Erectile dysfunction—Temozolomide—malignant glioma	0.000989	0.00943	CcSEcCtD
Simvastatin—Depression—Carmustine—malignant glioma	0.000988	0.00942	CcSEcCtD
Simvastatin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00098	0.00935	CcSEcCtD
Simvastatin—Neuropathy peripheral—Carmustine—malignant glioma	0.000971	0.00926	CcSEcCtD
Simvastatin—Depression—Temozolomide—malignant glioma	0.000955	0.00911	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000949	0.00906	CcSEcCtD
Simvastatin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000939	0.00895	CcSEcCtD
Simvastatin—ITGB2—brain—malignant glioma	0.000914	0.0488	CbGeAlD
Simvastatin—Sinusitis—Temozolomide—malignant glioma	0.000898	0.00857	CcSEcCtD
Simvastatin—Hepatitis—Temozolomide—malignant glioma	0.000859	0.0082	CcSEcCtD
Simvastatin—Flushing—Carmustine—malignant glioma	0.000825	0.00787	CcSEcCtD
Simvastatin—Erythema multiforme—Temozolomide—malignant glioma	0.000813	0.00775	CcSEcCtD
Simvastatin—Flushing—Temozolomide—malignant glioma	0.000798	0.00761	CcSEcCtD
Simvastatin—Alopecia—Carmustine—malignant glioma	0.000786	0.0075	CcSEcCtD
Simvastatin—Mental disorder—Carmustine—malignant glioma	0.000779	0.00743	CcSEcCtD
Simvastatin—Erythema—Carmustine—malignant glioma	0.000774	0.00739	CcSEcCtD
Simvastatin—Chills—Temozolomide—malignant glioma	0.000771	0.00736	CcSEcCtD
Simvastatin—Alopecia—Temozolomide—malignant glioma	0.00076	0.00725	CcSEcCtD
Simvastatin—Mental disorder—Temozolomide—malignant glioma	0.000753	0.00718	CcSEcCtD
Simvastatin—Erythema—Temozolomide—malignant glioma	0.000748	0.00714	CcSEcCtD
Simvastatin—Dysgeusia—Temozolomide—malignant glioma	0.000733	0.00699	CcSEcCtD
Simvastatin—Vision blurred—Carmustine—malignant glioma	0.00073	0.00696	CcSEcCtD
Simvastatin—Tremor—Carmustine—malignant glioma	0.000725	0.00692	CcSEcCtD
Simvastatin—HMGCR—telencephalon—malignant glioma	0.000723	0.0386	CbGeAlD
Simvastatin—Anaemia—Carmustine—malignant glioma	0.000716	0.00683	CcSEcCtD
Simvastatin—Vision blurred—Temozolomide—malignant glioma	0.000705	0.00673	CcSEcCtD
Simvastatin—Tremor—Temozolomide—malignant glioma	0.000701	0.00669	CcSEcCtD
Simvastatin—Ill-defined disorder—Temozolomide—malignant glioma	0.000694	0.00662	CcSEcCtD
Simvastatin—Leukopenia—Carmustine—malignant glioma	0.000693	0.00661	CcSEcCtD
Simvastatin—Anaemia—Temozolomide—malignant glioma	0.000692	0.0066	CcSEcCtD
Simvastatin—Angioedema—Temozolomide—malignant glioma	0.000684	0.00652	CcSEcCtD
Simvastatin—Malaise—Temozolomide—malignant glioma	0.000675	0.00644	CcSEcCtD
Simvastatin—Vertigo—Temozolomide—malignant glioma	0.000672	0.00641	CcSEcCtD
Simvastatin—Leukopenia—Temozolomide—malignant glioma	0.00067	0.00639	CcSEcCtD
Simvastatin—Myalgia—Carmustine—malignant glioma	0.000659	0.00629	CcSEcCtD
Simvastatin—Chest pain—Carmustine—malignant glioma	0.000659	0.00629	CcSEcCtD
Simvastatin—Anxiety—Carmustine—malignant glioma	0.000657	0.00627	CcSEcCtD
Simvastatin—Confusional state—Carmustine—malignant glioma	0.000637	0.00608	CcSEcCtD
Simvastatin—Arthralgia—Temozolomide—malignant glioma	0.000637	0.00608	CcSEcCtD
Simvastatin—Myalgia—Temozolomide—malignant glioma	0.000637	0.00608	CcSEcCtD
Simvastatin—Anxiety—Temozolomide—malignant glioma	0.000635	0.00606	CcSEcCtD
Simvastatin—Oedema—Carmustine—malignant glioma	0.000632	0.00603	CcSEcCtD
Simvastatin—Discomfort—Temozolomide—malignant glioma	0.000629	0.006	CcSEcCtD
Simvastatin—Infection—Carmustine—malignant glioma	0.000628	0.00599	CcSEcCtD
Simvastatin—Thrombocytopenia—Carmustine—malignant glioma	0.000619	0.0059	CcSEcCtD
Simvastatin—Confusional state—Temozolomide—malignant glioma	0.000616	0.00587	CcSEcCtD
Simvastatin—Anaphylactic shock—Temozolomide—malignant glioma	0.000611	0.00583	CcSEcCtD
Simvastatin—Oedema—Temozolomide—malignant glioma	0.000611	0.00583	CcSEcCtD
Simvastatin—Infection—Temozolomide—malignant glioma	0.000607	0.00579	CcSEcCtD
Simvastatin—Anorexia—Carmustine—malignant glioma	0.000602	0.00575	CcSEcCtD
Simvastatin—Thrombocytopenia—Temozolomide—malignant glioma	0.000598	0.0057	CcSEcCtD
Simvastatin—Anorexia—Temozolomide—malignant glioma	0.000582	0.00555	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000576	0.00549	CcSEcCtD
Simvastatin—Insomnia—Carmustine—malignant glioma	0.000572	0.00545	CcSEcCtD
Simvastatin—HMGCR—medulla oblongata—malignant glioma	0.000568	0.0304	CbGeAlD
Simvastatin—Paraesthesia—Carmustine—malignant glioma	0.000567	0.00541	CcSEcCtD
Simvastatin—SLCO1A2—telencephalon—malignant glioma	0.000564	0.0301	CbGeAlD
Simvastatin—Dyspnoea—Carmustine—malignant glioma	0.000563	0.00537	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000556	0.00531	CcSEcCtD
Simvastatin—Insomnia—Temozolomide—malignant glioma	0.000552	0.00527	CcSEcCtD
Simvastatin—Decreased appetite—Carmustine—malignant glioma	0.000549	0.00524	CcSEcCtD
Simvastatin—Paraesthesia—Temozolomide—malignant glioma	0.000548	0.00523	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Carmustine—malignant glioma	0.000546	0.0052	CcSEcCtD
Simvastatin—Dyspnoea—Temozolomide—malignant glioma	0.000544	0.00519	CcSEcCtD
Simvastatin—Pain—Carmustine—malignant glioma	0.00054	0.00515	CcSEcCtD
Simvastatin—Constipation—Carmustine—malignant glioma	0.00054	0.00515	CcSEcCtD
Simvastatin—Dyspepsia—Temozolomide—malignant glioma	0.000538	0.00513	CcSEcCtD
Simvastatin—Decreased appetite—Temozolomide—malignant glioma	0.000531	0.00506	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000527	0.00503	CcSEcCtD
Simvastatin—Fatigue—Temozolomide—malignant glioma	0.000526	0.00502	CcSEcCtD
Simvastatin—Pain—Temozolomide—malignant glioma	0.000522	0.00498	CcSEcCtD
Simvastatin—Constipation—Temozolomide—malignant glioma	0.000522	0.00498	CcSEcCtD
Simvastatin—Feeling abnormal—Carmustine—malignant glioma	0.000521	0.00497	CcSEcCtD
Simvastatin—HMGCR—midbrain—malignant glioma	0.000519	0.0278	CbGeAlD
Simvastatin—Gastrointestinal pain—Carmustine—malignant glioma	0.000517	0.00493	CcSEcCtD
Simvastatin—HMGCR—spinal cord—malignant glioma	0.000507	0.0271	CbGeAlD
Simvastatin—Feeling abnormal—Temozolomide—malignant glioma	0.000503	0.0048	CcSEcCtD
Simvastatin—Abdominal pain—Carmustine—malignant glioma	0.0005	0.00477	CcSEcCtD
Simvastatin—Body temperature increased—Carmustine—malignant glioma	0.0005	0.00477	CcSEcCtD
Simvastatin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000499	0.00476	CcSEcCtD
Simvastatin—Urticaria—Temozolomide—malignant glioma	0.000485	0.00463	CcSEcCtD
Simvastatin—Body temperature increased—Temozolomide—malignant glioma	0.000483	0.00461	CcSEcCtD
Simvastatin—Abdominal pain—Temozolomide—malignant glioma	0.000483	0.00461	CcSEcCtD
Simvastatin—Hypersensitivity—Carmustine—malignant glioma	0.000466	0.00444	CcSEcCtD
Simvastatin—Asthenia—Carmustine—malignant glioma	0.000453	0.00433	CcSEcCtD
Simvastatin—Hypersensitivity—Temozolomide—malignant glioma	0.00045	0.00429	CcSEcCtD
Simvastatin—SLCO1A2—medulla oblongata—malignant glioma	0.000443	0.0237	CbGeAlD
Simvastatin—Asthenia—Temozolomide—malignant glioma	0.000438	0.00418	CcSEcCtD
Simvastatin—Diarrhoea—Carmustine—malignant glioma	0.000432	0.00412	CcSEcCtD
Simvastatin—Pruritus—Temozolomide—malignant glioma	0.000432	0.00412	CcSEcCtD
Simvastatin—Dizziness—Carmustine—malignant glioma	0.000418	0.00399	CcSEcCtD
Simvastatin—Diarrhoea—Temozolomide—malignant glioma	0.000418	0.00399	CcSEcCtD
Simvastatin—HMGCR—central nervous system—malignant glioma	0.000411	0.022	CbGeAlD
Simvastatin—SLCO1A2—midbrain—malignant glioma	0.000405	0.0216	CbGeAlD
Simvastatin—Dizziness—Temozolomide—malignant glioma	0.000404	0.00385	CcSEcCtD
Simvastatin—Vomiting—Carmustine—malignant glioma	0.000402	0.00383	CcSEcCtD
Simvastatin—HMGCR—cerebellum—malignant glioma	0.000402	0.0215	CbGeAlD
Simvastatin—Rash—Carmustine—malignant glioma	0.000398	0.0038	CcSEcCtD
Simvastatin—Dermatitis—Carmustine—malignant glioma	0.000398	0.0038	CcSEcCtD
Simvastatin—Headache—Carmustine—malignant glioma	0.000396	0.00378	CcSEcCtD
Simvastatin—SLCO1A2—spinal cord—malignant glioma	0.000395	0.0211	CbGeAlD
Simvastatin—ABCB1—blood vessel—malignant glioma	0.000389	0.0208	CbGeAlD
Simvastatin—Vomiting—Temozolomide—malignant glioma	0.000388	0.0037	CcSEcCtD
Simvastatin—Rash—Temozolomide—malignant glioma	0.000385	0.00367	CcSEcCtD
Simvastatin—Dermatitis—Temozolomide—malignant glioma	0.000385	0.00367	CcSEcCtD
Simvastatin—Headache—Temozolomide—malignant glioma	0.000383	0.00365	CcSEcCtD
Simvastatin—Nausea—Carmustine—malignant glioma	0.000375	0.00358	CcSEcCtD
Simvastatin—Nausea—Temozolomide—malignant glioma	0.000363	0.00346	CcSEcCtD
Simvastatin—HMGCR—brain—malignant glioma	0.000326	0.0174	CbGeAlD
Simvastatin—SLCO1A2—central nervous system—malignant glioma	0.00032	0.0171	CbGeAlD
Simvastatin—SLCO1A2—cerebellum—malignant glioma	0.000313	0.0167	CbGeAlD
Simvastatin—CYP2D6—brainstem—malignant glioma	0.000296	0.0158	CbGeAlD
Simvastatin—CYP2D6—telencephalon—malignant glioma	0.000262	0.014	CbGeAlD
Simvastatin—SLCO1A2—brain—malignant glioma	0.000254	0.0136	CbGeAlD
Simvastatin—ABCB1—embryo—malignant glioma	0.000232	0.0124	CbGeAlD
Simvastatin—ABCB1—retina—malignant glioma	0.000205	0.011	CbGeAlD
Simvastatin—CYP2B6—central nervous system—malignant glioma	0.000201	0.0107	CbGeAlD
Simvastatin—ABCB1—telencephalon—malignant glioma	0.000189	0.0101	CbGeAlD
Simvastatin—CYP2C8—brain—malignant glioma	0.000178	0.0095	CbGeAlD
Simvastatin—CYP2B6—brain—malignant glioma	0.000159	0.00852	CbGeAlD
Simvastatin—CYP3A4—central nervous system—malignant glioma	0.000152	0.0081	CbGeAlD
Simvastatin—CYP2D6—central nervous system—malignant glioma	0.000149	0.00797	CbGeAlD
Simvastatin—ABCB1—medulla oblongata—malignant glioma	0.000148	0.00793	CbGeAlD
Simvastatin—CYP2D6—cerebellum—malignant glioma	0.000146	0.00779	CbGeAlD
Simvastatin—ABCB1—midbrain—malignant glioma	0.000136	0.00725	CbGeAlD
Simvastatin—ABCB1—spinal cord—malignant glioma	0.000132	0.00707	CbGeAlD
Simvastatin—CYP2D6—brain—malignant glioma	0.000118	0.00633	CbGeAlD
Simvastatin—ABCB1—central nervous system—malignant glioma	0.000107	0.00574	CbGeAlD
Simvastatin—ABCB1—cerebellum—malignant glioma	0.000105	0.00561	CbGeAlD
Simvastatin—ABCB1—brain—malignant glioma	8.52e-05	0.00455	CbGeAlD
Simvastatin—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.87e-05	0.000104	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—IDH2—malignant glioma	1.86e-05	0.000104	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.85e-05	0.000103	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CB—malignant glioma	1.84e-05	0.000103	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.84e-05	0.000103	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CAV1—malignant glioma	1.83e-05	0.000102	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTGS2—malignant glioma	1.83e-05	0.000102	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NCOR1—malignant glioma	1.83e-05	0.000102	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GSTP1—malignant glioma	1.82e-05	0.000102	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.8e-05	0.0001	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTT1—malignant glioma	1.78e-05	9.95e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CAT—malignant glioma	1.77e-05	9.88e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.77e-05	9.86e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.76e-05	9.82e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—IDH1—malignant glioma	1.76e-05	9.8e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.76e-05	9.8e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.75e-05	9.77e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTT1—malignant glioma	1.74e-05	9.72e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CD—malignant glioma	1.72e-05	9.62e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—IDH1—malignant glioma	1.72e-05	9.57e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.71e-05	9.56e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.7e-05	9.49e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SPHK1—malignant glioma	1.7e-05	9.49e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—NCOR1—malignant glioma	1.67e-05	9.33e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GSTP1—malignant glioma	1.67e-05	9.32e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS1—malignant glioma	1.67e-05	9.32e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CG—malignant glioma	1.67e-05	9.31e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.67e-05	9.29e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SPHK1—malignant glioma	1.66e-05	9.26e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS1—malignant glioma	1.63e-05	9.11e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CAT—malignant glioma	1.63e-05	9.07e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP2C18—malignant glioma	1.63e-05	9.07e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ASMT—malignant glioma	1.62e-05	9.04e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—IDH1—malignant glioma	1.62e-05	9.02e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PPARG—malignant glioma	1.61e-05	8.98e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.6e-05	8.94e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—IDH1—malignant glioma	1.6e-05	8.94e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CAV1—malignant glioma	1.59e-05	8.9e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTEN—malignant glioma	1.59e-05	8.89e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.57e-05	8.76e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SPHK1—malignant glioma	1.56e-05	8.72e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.56e-05	8.71e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—BCHE—malignant glioma	1.55e-05	8.66e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SPHK1—malignant glioma	1.55e-05	8.65e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.55e-05	8.63e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NCOR1—malignant glioma	1.54e-05	8.57e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.53e-05	8.56e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.53e-05	8.55e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—BCAN—malignant glioma	1.52e-05	8.5e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.52e-05	8.5e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.52e-05	8.47e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—BCHE—malignant glioma	1.52e-05	8.47e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.51e-05	8.43e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTT1—malignant glioma	1.51e-05	8.42e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CB—malignant glioma	1.5e-05	8.39e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.5e-05	8.36e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—malignant glioma	1.49e-05	8.31e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CAV1—malignant glioma	1.49e-05	8.3e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CD—malignant glioma	1.47e-05	8.18e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CG—malignant glioma	1.45e-05	8.1e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.43e-05	7.99e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.43e-05	7.98e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS1—malignant glioma	1.41e-05	7.89e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.41e-05	7.86e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPARG—malignant glioma	1.4e-05	7.82e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.38e-05	7.7e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CAV1—malignant glioma	1.36e-05	7.61e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CG—malignant glioma	1.36e-05	7.56e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTT1—malignant glioma	1.35e-05	7.52e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTT1—malignant glioma	1.31e-05	7.34e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—BCHE—malignant glioma	1.31e-05	7.33e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPARG—malignant glioma	1.31e-05	7.3e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.3e-05	7.28e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.3e-05	7.27e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTEN—malignant glioma	1.3e-05	7.25e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.3e-05	7.25e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CB—malignant glioma	1.28e-05	7.13e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CD—malignant glioma	1.28e-05	7.12e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.28e-05	7.12e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—malignant glioma	1.27e-05	7.07e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS1—malignant glioma	1.26e-05	7.04e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.26e-05	7.02e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.26e-05	7.02e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CAV1—malignant glioma	1.25e-05	6.98e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CG—malignant glioma	1.24e-05	6.93e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTT1—malignant glioma	1.24e-05	6.91e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTP1—malignant glioma	1.24e-05	6.89e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS1—malignant glioma	1.23e-05	6.87e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—IDH2—malignant glioma	1.23e-05	6.85e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTT1—malignant glioma	1.23e-05	6.85e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.23e-05	6.85e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.22e-05	6.79e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTP1—malignant glioma	1.21e-05	6.74e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CAT—malignant glioma	1.2e-05	6.71e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPARG—malignant glioma	1.2e-05	6.69e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CD—malignant glioma	1.19e-05	6.65e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CAT—malignant glioma	1.18e-05	6.56e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—BCHE—malignant glioma	1.17e-05	6.55e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS1—malignant glioma	1.16e-05	6.48e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.16e-05	6.47e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.16e-05	6.44e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS1—malignant glioma	1.15e-05	6.42e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.15e-05	6.4e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—BCHE—malignant glioma	1.15e-05	6.39e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.14e-05	6.36e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NCOR1—malignant glioma	1.14e-05	6.33e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—SLC5A5—malignant glioma	1.13e-05	6.31e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CA—malignant glioma	1.12e-05	6.27e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CB—malignant glioma	1.11e-05	6.21e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NCOR1—malignant glioma	1.11e-05	6.19e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTEN—malignant glioma	1.1e-05	6.16e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—malignant glioma	1.1e-05	6.15e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPARG—malignant glioma	1.1e-05	6.14e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.1e-05	6.12e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CD—malignant glioma	1.09e-05	6.09e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.09e-05	6.06e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—BCHE—malignant glioma	1.08e-05	6.02e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—BCHE—malignant glioma	1.07e-05	5.97e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.07e-05	5.95e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.06e-05	5.92e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.06e-05	5.9e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—IDH1—malignant glioma	1.06e-05	5.89e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTP1—malignant glioma	1.05e-05	5.84e-05	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.04e-05	5.81e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CB—malignant glioma	1.04e-05	5.8e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—malignant glioma	1.03e-05	5.74e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SPHK1—malignant glioma	1.02e-05	5.7e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CAT—malignant glioma	1.02e-05	5.68e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CD—malignant glioma	1e-05	5.59e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP2C18—malignant glioma	1e-05	5.59e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1e-05	5.58e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.9e-06	5.53e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTEN—malignant glioma	9.62e-06	5.37e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NCOR1—malignant glioma	9.61e-06	5.36e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CB—malignant glioma	9.52e-06	5.31e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.47e-06	5.28e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—malignant glioma	9.43e-06	5.26e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTP1—malignant glioma	9.34e-06	5.21e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CAV1—malignant glioma	9.26e-06	5.16e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—AKT1—malignant glioma	9.18e-06	5.12e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CA—malignant glioma	9.17e-06	5.11e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTP1—malignant glioma	9.11e-06	5.08e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CAT—malignant glioma	9.09e-06	5.07e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CAV1—malignant glioma	9.05e-06	5.05e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTEN—malignant glioma	8.98e-06	5.01e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CAT—malignant glioma	8.87e-06	4.95e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CB—malignant glioma	8.74e-06	4.87e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—malignant glioma	8.66e-06	4.83e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.64e-06	4.82e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTP1—malignant glioma	8.59e-06	4.79e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NCOR1—malignant glioma	8.58e-06	4.79e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTP1—malignant glioma	8.51e-06	4.75e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.43e-06	4.7e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NCOR1—malignant glioma	8.38e-06	4.67e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CAT—malignant glioma	8.36e-06	4.66e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CAT—malignant glioma	8.29e-06	4.62e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CG—malignant glioma	8.24e-06	4.6e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTEN—malignant glioma	8.23e-06	4.59e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPARG—malignant glioma	8.14e-06	4.54e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTT1—malignant glioma	8.1e-06	4.52e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPARG—malignant glioma	7.95e-06	4.44e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NCOR1—malignant glioma	7.89e-06	4.4e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CAV1—malignant glioma	7.84e-06	4.37e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NCOR1—malignant glioma	7.82e-06	4.36e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CA—malignant glioma	7.79e-06	4.35e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS1—malignant glioma	7.59e-06	4.23e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTEN—malignant glioma	7.55e-06	4.21e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.49e-06	4.18e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—AKT1—malignant glioma	7.49e-06	4.18e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.41e-06	4.14e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CD—malignant glioma	7.25e-06	4.04e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CG—malignant glioma	7.14e-06	3.98e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—BCHE—malignant glioma	7.06e-06	3.94e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CAV1—malignant glioma	7e-06	3.9e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.97e-06	3.89e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPARG—malignant glioma	6.89e-06	3.84e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CAV1—malignant glioma	6.83e-06	3.81e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CA—malignant glioma	6.79e-06	3.79e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.68e-06	3.73e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.46e-06	3.6e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CAV1—malignant glioma	6.43e-06	3.59e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—malignant glioma	6.4e-06	3.57e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CAV1—malignant glioma	6.38e-06	3.56e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.37e-06	3.55e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—AKT1—malignant glioma	6.37e-06	3.55e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CA—malignant glioma	6.33e-06	3.53e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.32e-06	3.52e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CD—malignant glioma	6.28e-06	3.5e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—malignant glioma	6.26e-06	3.49e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CG—malignant glioma	6.22e-06	3.47e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPARG—malignant glioma	6.15e-06	3.43e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.09e-06	3.4e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPARG—malignant glioma	6e-06	3.35e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.86e-06	3.27e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.81e-06	3.24e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CA—malignant glioma	5.8e-06	3.24e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPARG—malignant glioma	5.66e-06	3.16e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTP1—malignant glioma	5.62e-06	3.13e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPARG—malignant glioma	5.61e-06	3.13e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.6e-06	3.12e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTEN—malignant glioma	5.58e-06	3.11e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—AKT1—malignant glioma	5.54e-06	3.09e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CB—malignant glioma	5.47e-06	3.05e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CD—malignant glioma	5.47e-06	3.05e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CAT—malignant glioma	5.46e-06	3.05e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTEN—malignant glioma	5.46e-06	3.04e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—malignant glioma	5.42e-06	3.02e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.33e-06	2.97e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—AKT1—malignant glioma	5.17e-06	2.89e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NCOR1—malignant glioma	5.16e-06	2.88e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.15e-06	2.87e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.11e-06	2.85e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.88e-06	2.72e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—malignant glioma	4.84e-06	2.7e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CB—malignant glioma	4.77e-06	2.66e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—AKT1—malignant glioma	4.74e-06	2.64e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTEN—malignant glioma	4.73e-06	2.64e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—malignant glioma	4.72e-06	2.63e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.49e-06	2.51e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.45e-06	2.48e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—malignant glioma	4.45e-06	2.48e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—malignant glioma	4.41e-06	2.46e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—AKT1—malignant glioma	4.35e-06	2.43e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTEN—malignant glioma	4.22e-06	2.35e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CAV1—malignant glioma	4.21e-06	2.35e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTEN—malignant glioma	4.12e-06	2.3e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.94e-06	2.2e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTEN—malignant glioma	3.88e-06	2.16e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.85e-06	2.15e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTEN—malignant glioma	3.85e-06	2.15e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.83e-06	2.14e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPARG—malignant glioma	3.7e-06	2.06e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.37e-06	1.88e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.33e-06	1.86e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—AKT1—malignant glioma	3.22e-06	1.79e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—AKT1—malignant glioma	3.14e-06	1.75e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.98e-06	1.66e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.94e-06	1.64e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—malignant glioma	2.91e-06	1.62e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CA—malignant glioma	2.91e-06	1.62e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.74e-06	1.53e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—AKT1—malignant glioma	2.72e-06	1.52e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.71e-06	1.51e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTEN—malignant glioma	2.54e-06	1.42e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—AKT1—malignant glioma	2.43e-06	1.36e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—AKT1—malignant glioma	2.37e-06	1.32e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—AKT1—malignant glioma	2.24e-06	1.25e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—AKT1—malignant glioma	2.22e-06	1.24e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.79e-06	9.98e-06	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—AKT1—malignant glioma	1.46e-06	8.16e-06	CbGpPWpGaD
